TickerFactsScreenerDevelopers

Denali Therapeutics Inc. (DNLI) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2015: -$15.63M2016: -$94.15M2017: $465.80M2018: $546.85M2019: $394.89M2020: $1.15B2021: $962.29M2022: $1.04B2023: $1.03B2024: $1.23B2025: $1.01B$1.01B
2015Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$1.01B-17.6%
2024$1.23B+19.3%
2023$1.03B-1.1%
2022$1.04B+8.3%
2021$962.29M-16.4%
2020$1.15B+191.4%
2019$394.89M-27.8%
2018$546.85M+17.4%
2017$465.80M+594.7%
2016-$94.15M-502.2%
2015-$15.63M—